SAICScience Applications International Corporation Common Stock
- Next report
- Dec 3
- Thursday, in 21 days · time not announced yet
- EPS expected
- $2.33
- quarter ending Oct 31, 2026
- Last result
- $3.23Beat
- vs $2.26 expected on Jun 1
- Stock move on it
- +10.44%
- one session
- Price
- $130.85
- −1.85% today · $4.95B cap
Past and upcoming reports
2
| Dec 3, 2026 | Oct 31, 2026 | Time not announced yet | $2.33 | not yet | |
| Jun 1, 2026 | Apr 30, 2026 | Time not given | $2.26 | Beat$3.23 | +10.44% |
Pre-earnings read
No pre-earnings read for this report
None for this company right now.
After the report
Jun 1, 2026 report
SAIC Q1 EPS beats by 42% with modest 1.5% revenue growth, shares rise modestly
SAIC reported Q1 adjusted EPS of $3.23, beating estimates of $2.26 by 42%, while revenue grew 1.5% to $1.906 billion, reflecting operational strength amid weak top-line growth. Shares rose about 1.2% post-earnings. Market focus shifts to fiscal 2027 guidance for growth clarity.
Reported against expected
BeatQ1 EPS was $3.23 versus $2.26 estimate, a 41.8% beat. revenue grew 1.5% year-over-year to $1.906 billion.
Guidance
No explicit updated guidance disclosed. market awaits fiscal 2027 guidance for growth visibility.
How the stock reacted
Shares rose 1.2% to $114.73 two days post-earnings, with RSI at 77.5 indicating overbought conditions.
What changed
Q1 EPS beat estimates by 41.8% with EPS at $3.23 and revenue up 1.5% YoY.
What the price now assumes
Shares gained 1.2% post-earnings amid overbought RSI, reflecting cautious optimism on earnings strength.
What it means for the business
Maintain a constructive bias. monitor fiscal 2027 guidance for confirmation of growth trajectory.
The next one to three months, as we saw it then
Better case30%
Fiscal 2027 guidance shows acceleration in revenue growth and margin expansion, validating operational strength.
Base case50%
Revenue growth remains modest around 1-3%, EPS growth driven by efficiency. valuation remains attractive.
Worse case20%
Revenue declines persist, pressuring margins and causing multiple contraction despite EPS beats.
If you hold it
Hold unless fiscal 2027 revenue guidance falls below 1% growth or margins deteriorate materially.
If you are watching
Add only if fiscal 2027 guidance confirms revenue growth above 3% and margin improvement. avoid if guidance signals continued revenue weakness.
Scenario odds are a judgement, not measured.